Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Nass

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 2017
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic PainGiulia Donvito, Sara R Nass, Jenny L Wilkerson, et al.
Lupus|November 6, 2015
BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosusV F Picceli, T L Skare, R M Nisihara, et al.
Brain, Behavior, & Immunity - Health|October 21, 2020
Chronic HIV-1 Tat exposure alters anterior cingulate cortico-basal ganglia-thalamocortical synaptic circuitry, associated behavioral control, and immune regulation in male miceSara R Nass, Yun K Hahn, Virginia D McLane, et al.
Journal of Neurochemistry|February 3, 2024
HIV-1 Tat and morphine interactions dynamically shift striatal monoamine levels and exploratory behaviors over timeArianna R S Lark, Sara R Nass, Yun K Hahn, et al.
Journal of Neurophysiology|December 29, 2025
Acute fentanyl and xylazine co-exposure uniquely increase the excitability of dopamine type 2 receptor-expressing striatal medium spiny neuronsViktor Yarotskyy, Rachel M Schmitt, Hannah J Goudsward, et al.
ASN Neuro|March 9, 2023
Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal GangliaMichael Ohene-Nyako, Sara R Nass, Hope T Richard, et al.
ASN Neuro|January 13, 2025
Sex Affects Cognitive Outcomes in HIV-1 Tat Transgenic Mice: Role of CCR5Chloe A Simons, Sarah Kim, Yun K Hahn, et al.
American Journal of Physiology. Cell Physiology|January 26, 2022
Chloride channels with ClC-1-like properties differentially regulate the excitability of dopamine receptor D1- and D2-expressing striatal medium spiny neuronsViktor Yarotskyy, Arianna R S Lark, Sara R Nass, et al.
Drug and Alcohol Dependence|August 3, 2018
Novel behavioral assays of spontaneous and precipitated THC withdrawal in miceKristen R Trexler, Sara R Nass, Molly S Crowe, et al.
Viruses|March 30, 2023
Depressive-like Behavior Is Accompanied by Prefrontal Cortical Innate Immune Fatigue and Dendritic Spine Losses after HIV-1 Tat and Morphine ExposureSara R Nass, Yun K Hahn, Michael Ohene-Nyako, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 2017
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic PainGiulia Donvito, Sara R Nass, Jenny L Wilkerson, et al.
Lupus|November 6, 2015
BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosusV F Picceli, T L Skare, R M Nisihara, et al.
Brain, Behavior, & Immunity - Health|October 21, 2020
Chronic HIV-1 Tat exposure alters anterior cingulate cortico-basal ganglia-thalamocortical synaptic circuitry, associated behavioral control, and immune regulation in male miceSara R Nass, Yun K Hahn, Virginia D McLane, et al.
Journal of Neurochemistry|February 3, 2024
HIV-1 Tat and morphine interactions dynamically shift striatal monoamine levels and exploratory behaviors over timeArianna R S Lark, Sara R Nass, Yun K Hahn, et al.
Journal of Neurophysiology|December 29, 2025
Acute fentanyl and xylazine co-exposure uniquely increase the excitability of dopamine type 2 receptor-expressing striatal medium spiny neuronsViktor Yarotskyy, Rachel M Schmitt, Hannah J Goudsward, et al.
ASN Neuro|March 9, 2023
Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal GangliaMichael Ohene-Nyako, Sara R Nass, Hope T Richard, et al.
ASN Neuro|January 13, 2025
Sex Affects Cognitive Outcomes in HIV-1 Tat Transgenic Mice: Role of CCR5Chloe A Simons, Sarah Kim, Yun K Hahn, et al.
American Journal of Physiology. Cell Physiology|January 26, 2022
Chloride channels with ClC-1-like properties differentially regulate the excitability of dopamine receptor D1- and D2-expressing striatal medium spiny neuronsViktor Yarotskyy, Arianna R S Lark, Sara R Nass, et al.
Drug and Alcohol Dependence|August 3, 2018
Novel behavioral assays of spontaneous and precipitated THC withdrawal in miceKristen R Trexler, Sara R Nass, Molly S Crowe, et al.
Viruses|March 30, 2023
Depressive-like Behavior Is Accompanied by Prefrontal Cortical Innate Immune Fatigue and Dendritic Spine Losses after HIV-1 Tat and Morphine ExposureSara R Nass, Yun K Hahn, Michael Ohene-Nyako, et al.
Pageof 10